Skip to main content

Advertisement

Log in

Sentinel Lymph Node Biopsy in Multicentric Breast Cancer: Five-Year Results in a Large Series from a Single Institution

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

An Erratum to this article was published on 11 May 2011

Abstract

Purpose

This study was designed to present the 5-year results of patients with multicentric breast cancer who underwent sentinel lymph node biopsy (SLNB) in a single institution.

Methods

Between June 1999 and December 2007, 337 patients with multicentric breast cancer and a clinically negative axilla underwent lymphatic mapping by a single periareolar/peritumoral (n = 306) or a double peritumoral or subdermal injection (n = 31) of 99mTc-HSA nanocolloids. The sentinel lymph node (SLN) was evaluated by intraoperative frozen section and axillary dissection was performed only in cases of positive SLNB.

Results

The median age of the patients was 48 (range, 22–81) years. The mean number of hot spots identified was 1.4 in the whole series, 1.3 in patients who received a single injection, and 1.7 in those who received a double injection (P < 0.001). The mean number of removed SLNs was 1.7 (median, 1; range, 1–7) with an identification rate of 100%. A total of 138 patients with negative SLNB (n = 134) or isolated tumor cells in the SLN (n = 4) did not receive completion axillary lymph node dissection (CALND). In these latter patients, a total of 27 events (19.5%) occurred with 3 patients (2.2%) developing axillary recurrences after a median follow-up of 5 years (range, 17–134 months).

Conclusions

Axillary lymph node reappearance was infrequent among patients with multicentric breast cancer, having negative SLNB and no CALND. We recommend SLNB as the standard procedure for nodal staging in patients with multicentric breast cancer and a clinically negative axilla.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349:546–53.

    Article  PubMed  Google Scholar 

  2. Schrenk P, Wayand W. Sentinel-node biopsy in axillary lymph-node staging for patients with multicentric breast cancer. Lancet. 2001;357(9250):122.

    Article  PubMed  CAS  Google Scholar 

  3. Kim HJ, Heerdt AS, Cody III HS, Van Zee KJ. Sentinel node drainage in multicentric breast cancers. Breast J. 2002;8:356–361.

    Article  Google Scholar 

  4. Tousimis E, Van Zee KJ, Fey JV, et al. The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancers. J Am Coll Surg. 2003;197:529–35.

    Article  PubMed  Google Scholar 

  5. Goyal A, Newcombe RG, Mansel RE, et al. (2004) ALMANAC Trialists Group, Sentinel lymph node biopsy in patients with multifocal breast cancer. Eur J Surg Oncol. 30(5):475–9.

    Article  PubMed  CAS  Google Scholar 

  6. Kumar R, Jana S, Heiba SI, et al. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer. J Nucl Med. 2003;44(1):7–10.

    PubMed  Google Scholar 

  7. Mariani G, Moresco L, Viale G, et al. Radioguided sentinel lymph node biopsy in breast cancer surgery. J Nucl Med. 2001;42:1198–215.

    PubMed  CAS  Google Scholar 

  8. Klimberg VS, Rubio IT, Henry R, et al. Subareolar versus peritumoral injection for location of the sentinel node. Ann Surg. 1999;229:860–5.

    Article  PubMed  CAS  Google Scholar 

  9. Giard S, Chauvet M-P, Penel N, et al. Feasibility of sentinel lymph node biopsy in multiple unilateral synchronous breast cancer: results of a French prospective multi-institutional study (IGASSU 0502). Ann Oncol. 2010;21(8):1630–5. Epub 2010 Jan 20.

    Google Scholar 

  10. Gentilini O, Trifirò G, Soteldo J, et al. Sentinel lymph node biopsy in multicentric breast cancer. The experience of the European Institute of Oncology. Eur J Surg Oncol. 2006;32(5):507–10. Epub 2006 Apr 3.

    Google Scholar 

  11. Marubini E., Valsecchi M.G. Analysing survival data from clinical trials and observational studies. Chichester, England: Wiley 1995: 331.

  12. International Breast Cancer Study Group, Rudenstam CM, Zahrieh D, Forbes JF, et al. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10–93. J Clin Oncol. 2006;24(3):337–44. Epub 2005 Dec 12.

    Google Scholar 

  13. Goldhirsch A, Ingle JN, Gelber RD, Coates AS, Thürlimann B, Senn H-J and Panel members. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol. 2009;20(8):1319–29. Epub 2009 Jun 17.

  14. Carpenter S, Fraser J, Fleming M, Gray R, Halyard M, Pockaj B. Optimal treatment of multiple ipsilateral primary breast cancers. Am J Surg. 2008;196(4):530–6.

    Article  PubMed  Google Scholar 

  15. Mamounas EP, Brown A, Anderson S, et al. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from the National Surgical Adjuvant Breast and Bowel Project protocol B-27. J Clin Oncol. 2005;23:2694–702.

    Article  PubMed  Google Scholar 

  16. Giuliano AE, McCall L, Beitsch P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases. Ann Surg. 2010;252(3):426–32; discussion 432–3.

    Google Scholar 

  17. Veronesi U, Galimberti V, Paganelli G, et al. (2009) Axillary metastases in breast cancer patients with negative sentinel nodes: a follow up of 3548 cases. Eur J Cancer. 45(8):1381–8. Epub 2009 Jan 6.

    Google Scholar 

  18. Tuttle TM, Colbert M, Christensen R, et al. Subareolar injection of 99mTc facilitates sentinel lymph node identification. Ann Surg Oncol. 2002;9(1):77–81.

    Article  PubMed  Google Scholar 

  19. Bauer TW, Spitz FR, Callans LS, et al. Subareolar and peritumoral injection identify similar sentinel nodes for breast cancer. Ann Surg Oncol. 2002;9(2):169–76.

    Article  PubMed  Google Scholar 

  20. Paganelli G, Galimberti V, Trifiro’ G, et al. Internal mammary node lymphoscintigraphy and biopsy in breast cancer. Q J Nucl Med. 2002;46:138–44.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgment

The authors are greatly thankful to A.I.R.C. (Associazione Italiana per la Ricerca contro il Cancro), which supported clinical research on sentinel lymph node biopsy. We also thank William Russell-Edu, Librarian, European Institute of Oncology, for revising the English text and the Umberto Veronesi Foundation for supporting this research.

Disclosure

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Oreste Gentilini MD.

Additional information

An erratum to this article can be found at http://dx.doi.org/10.1245/s10434-011-1760-x

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gentilini, O., Veronesi, P., Botteri, E. et al. Sentinel Lymph Node Biopsy in Multicentric Breast Cancer: Five-Year Results in a Large Series from a Single Institution. Ann Surg Oncol 18, 2879–2884 (2011). https://doi.org/10.1245/s10434-011-1694-3

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-011-1694-3

Keywords

Navigation